GB1289873A - - Google Patents

Info

Publication number
GB1289873A
GB1289873A GB1289873DA GB1289873A GB 1289873 A GB1289873 A GB 1289873A GB 1289873D A GB1289873D A GB 1289873DA GB 1289873 A GB1289873 A GB 1289873A
Authority
GB
United Kingdom
Prior art keywords
chloromadinone acetate
methyl
chloromadinone
acetate
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1289873A publication Critical patent/GB1289873A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1289873D 1969-10-09 1970-09-07 Expired GB1289873A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691950858 DE1950858A1 (de) 1969-10-09 1969-10-09 Verfahren zur Konzeptionsverhuetung

Publications (1)

Publication Number Publication Date
GB1289873A true GB1289873A (cg-RX-API-DMAC10.html) 1972-09-20

Family

ID=5747704

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1289873D Expired GB1289873A (cg-RX-API-DMAC10.html) 1969-10-09 1970-09-07

Country Status (4)

Country Link
DE (1) DE1950858A1 (cg-RX-API-DMAC10.html)
FR (1) FR2081321A1 (cg-RX-API-DMAC10.html)
GB (1) GB1289873A (cg-RX-API-DMAC10.html)
ZA (1) ZA706105B (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
DE1950858A1 (de) 1971-05-06
ZA706105B (en) 1971-05-27
FR2081321A1 (cg-RX-API-DMAC10.html) 1971-12-03

Similar Documents

Publication Publication Date Title
US3568828A (en) Modified sequential oral contraceptive
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
GB1459675A (en) Method for the prevention of conception
SE7416039L (cg-RX-API-DMAC10.html)
GB1384214A (en) Oral contraceptive regimens and packaged unit dosage forms thereof
GB1433032A (en) Contraceptive method and preparations
Tillander et al. EXCRETION RATE OF METHYL MERCURY IN THE SEAL(PUSA HISPIDA)
GB1380171A (en) Medicinal tablets
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
GB1292496A (en) Dosage units of contraceptive preparations for human use
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1488995A (en) Compositions containing anti-androgenic compounds
Szontagh et al. Post-coital contraception with dienoestrol
GB950162A (en) Medicines for the treatment of hepatic disorders
US3660574A (en) Method of controlling fertility employing quingestanol acetate
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB1474749A (en) Pharmaceutical preparations based on cyproterone
GB1304239A (cg-RX-API-DMAC10.html)
Asbjorn et al. Low dose of gestagen as a contraceptive method. A clinical trial
Suran Ovulation inhibition with sequential therapy. A continuing clinical study of fertility control
Talwar et al. Increased risk of breakthrough bleeding when one oral-contraceptive tablet is missed
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
Koetsawang et al. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel
GB1298587A (en) Methods of contraception and contraceptive compositions

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees